Next-Gen Phenotypic Profiling of Antivirals with AI-Driven Image Analysis
A Collaboration Between the Ultra-Fast Araceli Endeavor® Platform and ViQi’s Predictive Analytics
Based on research conducted by the Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
Fast, high resolution live cell imaging, combined with automated, AI-based analysis.
In this joint application note, ViQi, Inc. and Araceli Biosciences demonstrate how combining ultra-fast, high-content imaging from the Araceli Endeavor® with ViQi’s powerful AI-driven analysis platforms—AVIA™ and AutoHCS™—can accelerate the discovery of effective antiviral compounds. By enabling rapid, live-cell, information-dense screening with automated, scalable analysis, this partnership delivers a next-generation approach to phenotypic profiling that is faster, more precise, and cost-effective. This workflow was deployed at the Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology to identify candidate antivirals targeting the Zika virus.